Engineering pancreatic islets with a novel form of thrombomodulin protein to overcome early graft loss triggered by instant blood-mediated inflammatory reaction
Open Access
- 28 February 2023
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (5) , 619-628
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 58 references indexed in Scilit:
- Activated Protein C Inhibits Pancreatic Islet Inflammation, Stimulates T Regulatory Cells, and Prevents Diabetes in Non-obese Diabetic (NOD) MiceJournal of Biological Chemistry, 2012
- Pancreatic Islets Engineered with SA-FasL Protein Establish Robust Localized Tolerance by Inducing Regulatory T Cells in MiceThe Journal of Immunology, 2011
- Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunityBlood, 2011
- Tumor cells engineered to codisplay on their surface 4-1BBL and LIGHT costimulatory proteins as a novel vaccine approach for cancer immunotherapyCancer Gene Therapy, 2010
- Biomolecular surface engineering of pancreatic islets with thrombomodulinActa Biomaterialia, 2010
- Thrombomodulin Improves Early Outcomes After Intraportal Islet TransplantationAmerican Journal of Transplantation, 2009
- Proteolytic Cleavage of High Mobility Group Box 1 Protein by Thrombin-Thrombomodulin ComplexesArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- A New T-Cell Receptor Transgenic Model of the CD4+ Direct Pathway: Level of Priming Determines Acute Versus Chronic RejectionTransplantation, 2008
- Surface Re-engineering of Pancreatic Islets with Recombinant azido-ThrombomodulinBioconjugate Chemistry, 2007
- Interference with Tissue Factor Prolongs Intrahepatic Islet Allograft Survival in a Nonhuman Primate Marginal Mass ModelTransplantation, 2007